This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated CEP290 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-CEP290 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~290.4 kDa | |
| Gel | 4–12% gradient (standard starting point) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Soft tissue (IHC candidate; verify WB) |
| PTM | Ubl conjugation | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A01894 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HCT116 (40ug), SGC7901 (40ug), COS-7 (40ug) (catalog A01894) |
| Gel % | 4–12% gradient (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A01894; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
CEP290 is predicted at 290.4 kDa; its listed features do not demonstrate different migration, and no empirical band size is supplied.
| Band near 290.4 kDa | Consistent with the predicted size of full-length CEP290; confirm its identity |
| Faint band near 290.4 kDa in whole-cell lysate | CEP290 may be poorly recovered from its centrosomal and cytoskeletal locations |
| No band in a soluble fraction | Centrosomal or cytoskeletal CEP290 may remain in the insoluble fraction |
| Stronger band near 290.4 kDa in a cytoskeletal fraction | Consistent with enrichment of localized CEP290; confirm its identity |
| UniProt predicted mass | Places full-length CEP290 at 290.4 kDa by sequence calculation |
| 290386 Da calculated mass | Corresponds to approximately 290.4 kDa for full-length CEP290 |
| Full-length sequence prediction | Provides a size reference without establishing electrophoretic migration |
| Single listed isoform | Provides no evidence for a second isoform band at a different size |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Centrosomal and cytoskeletal CEP290 may be poorly recovered in the tested fraction | Check fraction recovery and include a positive control |
| Band higher than expected | The supplied features do not establish the cause | Confirm identity with CEP290 depletion or a second antibody |
| Band lower than expected | The supplied features do not establish a cleavage product | Check sample integrity and confirm identity with a second antibody |
| Multiple bands | No distinct isoform masses or processing products are supplied to identify them | Check which bands disappear after CEP290 depletion |
| Weak or no signal | Recovery of localized CEP290 may be low | Assess extraction and loading with a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | ciliated cells (cell body) | High | Protein (IHC) | HPA → |
| Cerebellum | cells in granular layer | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Soft tissue | chondrocytes | Not detected | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Low | Protein (IHC) | HPA → |
| Epididymis | glandular cells | Low | Protein (IHC) | HPA → |
| Skeletal muscle | myocytes | Low | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Medium | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for CEP290, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Three the supplier anti-CEP290 polyclonal antibodies are listed with WB images. A01894 has a caption naming seven cell lysates, 40 µg per lane, and a 1:500 dilution; the other two captions describe only unspecified cells.
Which to pick: Choose A01894 if you need reported rat reactivity or a WB example with named lysates and conditions. A01894-1 and A30603 list human and mouse reactivity, but their WB captions give no specific samples or conditions.